Could a Mitochondria-Boosting supplement beat multivitamins for preventing colds?

NCT ID NCT07622147

Not yet recruiting Prevention Sponsor: MIPO Clinic Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 30, 2026 · Updated 3 times

Summary

This study tests whether a special combination of supplements (sodium nucleinate, magnesium, vitamin B6, and high-dose vitamin D) can prevent respiratory infections like colds and flu better than standard multivitamins. Two hundred healthy male military recruits in Kazakhstan will take either the new supplement or a standard multivitamin daily for 30 days, and researchers will track infections and immune cell function over 6 months. The goal is to see if boosting the power source inside immune cells (mitochondria) can help prevent infections during the stressful adaptation period of military training.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: sodium nucleinate, magnesium, vitamin B6, and vitamin D3 5000 IU
What this could lead to: If it works, this could lead to a better prevention strategy for respiratory infections in high-risk groups like military recruits.
What could go wrong: This is a small, early-stage trial with only 200 participants, so results may not apply to the general population. The intervention is a dietary supplement, so any effect is likely modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNO-MODULATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

meningitis respiratory tract infectious disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IMMUNO-MODULATION IMMUNO-MONITORING MENINGITIS MITOCHONDRIAL BIOMARKERS PRIMARY PREVENTION PRIMARY PREVENTION/METHODS RESPIRATORY TRACT INFECTIONS (RTI)

More trials for these conditions

Other studies related to the condition(s) this trial covers.